FI119059B - Ihmisestä peräisin olevat Lactobacillus-kannat, niiden koostumukset ja niiden käytöt - Google Patents

Ihmisestä peräisin olevat Lactobacillus-kannat, niiden koostumukset ja niiden käytöt Download PDF

Info

Publication number
FI119059B
FI119059B FI964681A FI964681A FI119059B FI 119059 B FI119059 B FI 119059B FI 964681 A FI964681 A FI 964681A FI 964681 A FI964681 A FI 964681A FI 119059 B FI119059 B FI 119059B
Authority
FI
Finland
Prior art keywords
cncm
strains
lactobacillus
atcc
lactobacilli
Prior art date
Application number
FI964681A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI964681A (fi
FI964681A0 (fi
Inventor
Haen Christoph De
Lorenzo Morelli
Vittorio Bottazzi
Luigia Gozzini
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI119059(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI941073A external-priority patent/IT1269838B/it
Priority claimed from ITMI941773A external-priority patent/IT1274733B/it
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of FI964681A0 publication Critical patent/FI964681A0/fi
Publication of FI964681A publication Critical patent/FI964681A/fi
Application granted granted Critical
Publication of FI119059B publication Critical patent/FI119059B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI964681A 1994-05-26 1996-11-25 Ihmisestä peräisin olevat Lactobacillus-kannat, niiden koostumukset ja niiden käytöt FI119059B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
ITMI941073A IT1269838B (it) 1994-05-26 1994-05-26 Ceppi di lattobacilli di origine umana e loro usi
ITMI941073 1994-05-26
ITMI941773 1994-08-25
ITMI941773A IT1274733B (it) 1994-08-25 1994-08-25 Ceppo del genere lactobacillus di origine umana e suoi usi
EP9501886 1995-05-18
PCT/EP1995/001886 WO1995033046A1 (en) 1994-05-26 1995-05-18 Lactobacillus strains of human origin, their compositions and uses thereof

Publications (3)

Publication Number Publication Date
FI964681A0 FI964681A0 (fi) 1996-11-25
FI964681A FI964681A (fi) 1997-01-08
FI119059B true FI119059B (fi) 2008-07-15

Family

ID=26331139

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964681A FI119059B (fi) 1994-05-26 1996-11-25 Ihmisestä peräisin olevat Lactobacillus-kannat, niiden koostumukset ja niiden käytöt

Country Status (18)

Country Link
US (1) US5709857A (de)
EP (1) EP0760848B1 (de)
JP (1) JP3653277B2 (de)
CN (1) CN1094972C (de)
AT (1) ATE163042T1 (de)
AU (1) AU686389B2 (de)
BR (1) BR9507752A (de)
CA (1) CA2191213C (de)
DE (2) DE760848T1 (de)
DK (1) DK0760848T3 (de)
ES (1) ES2099056T3 (de)
FI (1) FI119059B (de)
GR (2) GR970300016T1 (de)
HU (1) HU220190B (de)
MX (1) MX9605807A (de)
NO (1) NO316644B1 (de)
NZ (1) NZ287420A (de)
WO (1) WO1995033046A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN175495A0 (en) * 1995-03-14 1995-04-13 University Of New England, The Method and composition for the prevention of the over production of acid
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
IT1289159B1 (it) 1997-01-08 1998-09-29 Yurta S R L Composizioni farmaceutiche e alimentari a base di batteri del genere acetobacter
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
US7202219B1 (en) * 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
DE69802260T2 (de) 1998-04-30 2002-07-04 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
HUP0200374A2 (en) 1999-03-11 2002-06-29 Nestle Sa Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
EP1034788A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Milchsäure Bakterienstämme zur Verhinderung von Diarrhöe
EP1034787A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
US20040105848A1 (en) * 1999-04-30 2004-06-03 Natarajan Ranganathan Enteric dialysis compositions and methods
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) * 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
AU2001233529A1 (en) 2000-02-10 2001-08-20 Andrew W. Bruce Probiotic therapy for newborns
EP1303256B1 (de) 2000-06-09 2009-01-07 Baylor College of Medicine Kombination von antimikrobiellen wirkstoffen und bakterieller interferenz zum überziehen medizinischer vorrichtungen
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
IL156490A0 (en) 2000-12-18 2004-01-04 Probiohealth Probiotic compounds derived from lactobacillus casei strain ke01
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
NO318426B1 (no) * 2001-10-02 2005-04-18 Neurozym Biotech As Et materiale for a senke konsentrasjonen av patogene tarmpeptider
US8147821B2 (en) 2002-02-21 2012-04-03 Grain Processing Corporation Method for drying biomaterials
EP1485463B1 (de) 2002-03-21 2008-09-24 Bifodan A/S Lactobacillus-stämme
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
CA2547144C (en) 2005-05-16 2010-02-02 Grain Processing Corporation Method for drying spent filter media
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
EP2016834B1 (de) * 2007-07-13 2009-11-04 Unilever N.V. Nahrungsmittel mit Bakterien und Sorbitan-Fettsäure
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
EP2293802A4 (de) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc Lactosezusammensetzungen mit reduziertem lactosegehalt
KR101003149B1 (ko) * 2008-10-31 2010-12-22 전남대학교산학협력단 병변 치료용 박테리아 기반의 마이크로로봇
EP2206506A1 (de) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotische Formulierungen
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
KR20110124780A (ko) 2009-02-24 2011-11-17 리터 파마슈티컬즈 인코오포레이티드 프리바이오틱 제제 및 사용 방법
EP2248908A1 (de) 2009-05-05 2010-11-10 Eurolactis Group S.A. Aus Eselsmilch isolierte probiotische Mikroorganismen
WO2011009848A2 (en) 2009-07-20 2011-01-27 Bracco Spa Therapeutic use of probiotics
EP3311825A1 (de) 2010-08-04 2018-04-25 Thomas Julius Borody Zusammensetzungen zur darmfloratransplantation und verfahren zur herstellung davon und verwendung davon
EP2683390B1 (de) 2011-03-09 2017-05-03 Regents Of The University Of Minnesota Zusammensetzungen und verfahren zur transplantation von biozönose des kolon
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
AU2013322644B2 (en) * 2012-09-25 2019-05-16 Aquilon Cyl S.L. Probiotic and prebiotic compositions
AU2016262615C1 (en) 2015-05-14 2021-06-10 Finch Therapeutics Holdings Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CN114366759A (zh) 2015-05-22 2022-04-19 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
CN110831606A (zh) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 治疗帕金森氏病(pd)和相关疾病的组合物和方法
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
WO2018218159A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
WO2019032573A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
JP2022514145A (ja) 2018-09-27 2022-02-10 フィンチ セラピューティクス ホールディングス エルエルシー てんかんおよび関連する障害を治療するための組成物および方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
EP0577904B1 (de) * 1992-07-06 1997-05-14 Societe Des Produits Nestle S.A. Milchbakterien

Also Published As

Publication number Publication date
US5709857A (en) 1998-01-20
GR970300016T1 (en) 1997-05-31
DK0760848T3 (da) 1998-09-23
JPH10500577A (ja) 1998-01-20
NO964966L (no) 1997-01-23
ATE163042T1 (de) 1998-02-15
NO964966D0 (no) 1996-11-22
MX9605807A (es) 1997-12-31
NO316644B1 (no) 2004-03-22
DE69501591T2 (de) 1998-06-10
FI964681A (fi) 1997-01-08
BR9507752A (pt) 1997-10-07
JP3653277B2 (ja) 2005-05-25
AU686389B2 (en) 1998-02-05
WO1995033046A1 (en) 1995-12-07
EP0760848A1 (de) 1997-03-12
CA2191213C (en) 2008-03-18
HUT75555A (en) 1997-05-28
ES2099056T3 (es) 1998-04-01
NZ287420A (en) 1997-12-19
HU220190B (hu) 2001-11-28
GR3026758T3 (en) 1998-07-31
ES2099056T1 (es) 1997-05-16
AU2613995A (en) 1995-12-21
CA2191213A1 (en) 1995-12-07
DE760848T1 (de) 1997-08-28
DE69501591D1 (de) 1998-03-12
FI964681A0 (fi) 1996-11-25
CN1154715A (zh) 1997-07-16
EP0760848B1 (de) 1998-02-04
CN1094972C (zh) 2002-11-27
HU9603251D0 (en) 1997-01-28

Similar Documents

Publication Publication Date Title
FI119059B (fi) Ihmisestä peräisin olevat Lactobacillus-kannat, niiden koostumukset ja niiden käytöt
JP4350170B2 (ja) ラクトバチルス・カセイ・ラムノススを含む薬学的調製物
KR100386144B1 (ko) 헬리코박터 파일로리 （Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ）제균성 식음료 제품
HU218350B (hu) A bél és/vagy gyomorsejtekről a Helicobacter pylorit leszárítani képes CNCM I-1225 törzs tenyészetéből származó felülúszó fázis és ezt, vagy a törzs tenyészetét tartalmazó élelmiszer- és gyógyszerkészítmények
EP0154549A2 (de) Anti-Karies- oder Anti-Periodontitismittel
EP1802318A1 (de) Milchsäurebakterien-stämme gegen gastrointestinale erreger und diese enthaltende zusammensetzungen
US20230031534A1 (en) Methods for alleviating enteric pathogenic bacterium-associated disorder and inhibiting growth of enteric pathogenic bacteria
US20230201280A1 (en) Methods for improving gastrointestinal barrier function and inhibiting growth of enteric pathogenic bacteria
JPS62145026A (ja) 抗発癌剤
WO2008077229A1 (en) Growth inhibition of microorganisms by lactic acid bacteria
US20070134220A1 (en) Lactobacillus fermentum strain and uses thereof
JP2006508943A (ja) 酵母成長を阻害するための方法
ES2296635T3 (es) Bifidobacteria capaz de prevenir la diarrea.
Romond et al. Cell-free wheys from bifidobacteria fermented milks exert a regulatory effect on the intestinal microflora of mice and humans
US20030077255A1 (en) Compositions of bacteria and alpha-lactalbumin and uses thereof
JP2001002578A (ja) Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性医薬品
Fauziah et al. Effects of Lactobacillus bulgaricus in soyghurt on inhibition of adhesion Klebsiella pneumoniae strains in HEp-2 cell lines
JP2012147759A (ja) ヘリコバクター・ピロリ及びその他の病原菌を抑制するラクトバシラス属乳酸菌を含有する新規納豆
US11896632B2 (en) Methods for inhibiting growth of oral pathogenic bacteria and alleviating oral pathogenic bacteria-associated disorder
Suresh et al. Antibacterial activity of Lactobacillus (LB) strains isolated from goat milk against ESBL producing E. coli causing wound infections
Hoseinian et al. Lactobacillus spp. Inhibit the Biofilm Formation of Pseudomonas aeruginosa
CN118879561A (zh) 凝结魏茨曼氏菌zt05及其后生元在制备预防和/或治疗龋齿和牙周病药物中的应用
ITMI941073A1 (it) Ceppi di lattobacilli di origine umana e loro usi
ITMI941773A1 (it) Ceppo del genere lactobacillus di origine umana e suoi usi
KR20080020199A (ko) 충치균 성장을 억제하는 항균제를 생성하는 락토바실루스파라플란타룸 ｋｎｕｃ25로부터 제조된 충치균 항균제

Legal Events

Date Code Title Description
MM Patent lapsed